ACTG Publications

TitleAuthorsDateJournalIssueVolume
Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).McKinnon, John E ; Mailliard, Robbie B ; Swindells, Susan ; Wilkin, Timothy J ; Borowski, Luann ; Roper, Jillian M ; Bastow, Barbara ; Kearney, Mary ; Wiegand, Ann ; Mellors, John W ; Rinaldo, Charles R ; A5201 study team2014PLoS One59
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.Gandhi, Rajesh T ; Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Palmer, Sarah ; Medvik, Kathy ; Lederman, Michael M ; Alatrakchi, Nadia ; Jacobson, Jeffrey M ; Wiegand, Ann ; Kearney, Mary ; Coffin, John M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group A5244 team2010PLoS Med87
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.Halvas, Elias K ; Wiegand, Ann ; Boltz, Valerie F ; Kearney, Mary ; Nissley, Dwight ; Wantman, Michael ; Hammer, Scott M ; Palmer, Sarah ; Vaida, Florin ; Coffin, John M ; Mellors, John W2010 MarJ Infect Dis5201
Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults.Kearney, Mary F ; Spindler, Jonathan ; Wiegand, Ann ; Shao, Wei ; Haubrich, Richard ; Riddler, Sharon ; Lalama, Christina M ; Hughes, Michael D ; Coffin, John M ; Mellors, John W2018PLoS One113
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.Gandhi, Rajesh T ; Coombs, Robert W ; Chan, Ellen S ; Bosch, Ronald J ; Zheng, Lu ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Chang, Ming ; Goecker, Erin A ; Wiegand, Ann ; Kearney, Mary ; Jacobson, Jeffrey M ; D'Aquila, Richard ; Lederman, Michael M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group (ACTG) A52442012 Mar 1J Acquir Immune Defic Syndr359
Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.Kearney, Mary F ; Wiegand, Ann ; Shao, Wei ; Coffin, John M ; Mellors, John W ; Lederman, Michael ; Gandhi, Rajesh T ; Keele, Brandon F ; Li, Jonathan Z2016 FebJ Virol390
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.Wilkin, Timothy J ; McKinnon, John E ; DiRienzo, A Gregory ; Mollan, Katie ; Fletcher, Courtney V ; Margolis, David M ; Bastow, Barbara ; Thal, Gary ; Woodward, William ; Godfrey, Catherine ; Wiegand, Ann ; Maldarelli, Frank ; Palmer, Sarah ; Coffin, John M ; Mellors, John W ; Swindells, Susan2009 Mar 15J Infect Dis6199